Current Readings: Management of N2 Disease for Lung Cancer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The optimal management of locally advanced, Stage IIIA NSCLC with N2 level nodal metastases remains challenging and controversial. A number of treatment regimens have been shown safe and effective, but existing clinical trial data frequently falls short of providing guidance to match the right approach with the right patient. We review recent literature in this area and its impact.

Original languageEnglish (US)
Pages (from-to)67-70
Number of pages4
JournalSeminars in thoracic and cardiovascular surgery
Issue number1
StatePublished - 2014


  • Chemotherapy
  • Genomics
  • Lung cancer
  • N2 NSCLC
  • Radiation therapy
  • Surgery
  • Targeted therapy

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Current Readings: Management of N2 Disease for Lung Cancer'. Together they form a unique fingerprint.

Cite this